Adverse events12

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 12 of 12

Type	Event	Organ system	Group	Affected	At risk	Events
other	Headache	Nervous system disorders	Diclofenac Sodium Gel	4	398	5
other	Headache	Nervous system disorders	Voltaren® Gel	9	405	12
other	Headache	Nervous system disorders	Placebo Gel	11	400	14
other	Pyrexia	General disorders	Diclofenac Sodium Gel	6	398	6
other	Pyrexia	General disorders	Voltaren® Gel	6	405	9
other	Pyrexia	General disorders	Placebo Gel	9	400	11
other	Eosinophilia	Blood and lymphatic system disorders	Diclofenac Sodium Gel	1	398	1
other	Eosinophilia	Blood and lymphatic system disorders	Voltaren® Gel	4	405	4
other	Eosinophilia	Blood and lymphatic system disorders	Placebo Gel	0	400	0
serious	Completed Suicide	Psychiatric disorders	Diclofenac Sodium Gel	0	398	0
serious	Completed Suicide	Psychiatric disorders	Voltaren® Gel	1	405	1
serious	Completed Suicide	Psychiatric disorders	Placebo Gel	0	400	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03172780/events